What Are GLP-1 Meds and How Do They Work?

Last reviewed: June 16, 2026

Last updated: June 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

GLP-1 receptor agonists are medications that mimic a hormone your gut naturally produces after eating. Clinical trials show these drugs reduce hunger signals in the brain while improving how your body handles blood sugar, making sustained weight loss achievable for many patients. PlexusDx specializes in personalized GLP-1 therapy tailored to your unique genetic profile.

How GLP-1 Medications Control Hunger and Weight

When you eat, your intestines release glucagon-like peptide-1 (GLP-1), a natural hormone that tells your brain you're satisfied. GLP-1 medications amplify this signal, making you feel full on smaller meals and reducing cravings between eating times. This biological mechanism works at the neurological level, not through willpower or restriction alone.

Beyond appetite, GLP-1 drugs slow gastric emptying—the rate food leaves your stomach—which extends that feeling of fullness for hours. They also improve insulin secretion when blood sugar rises, helping your body maintain stable glucose levels throughout the day. These combined effects address both hunger and metabolic regulation simultaneously.

The Science Behind GLP-1 Receptor Activation

Your body has GLP-1 receptors located in the brain, pancreas, and digestive tract. When medications like semaglutide bind to these receptors, they trigger a cascade of biological signals that reduce appetite hormones and increase satiety hormones like peptide YY. This receptor activation is the same pathway your body naturally uses after a meal, which is why the approach feels physiologically aligned rather than forced.

Research shows GLP-1 receptor agonists also interact with other appetite-control pathways, including those involving leptin and melanocortin-4 receptor (MC4R) signaling. Individual genetic variations in these pathways—such as the FTO rs9939609 variant or MC4R rs17782313 polymorphism—influence how strongly each person responds to GLP-1 therapy. PlexusDx uses the Precision Peptide Genetic Test to map your specific peptide-pathway genetics and predict your likely medication response.

Semaglutide vs. Other GLP-1 Options: What's Different

Semaglutide is a GLP-1 agonist with a half-life of approximately seven days, meaning one injection weekly maintains steady medication levels in your bloodstream. This weekly dosing schedule simplifies adherence compared to daily medications. Tirzepatide, another option, is a dual GIP/GLP-1 receptor agonist that activates two complementary appetite pathways simultaneously, which some patients find more effective for stubborn weight loss.

Oral formulations of semaglutide and tirzepatide are available for patients who prefer not to inject, though they typically require more frequent dosing and higher starting prices. PlexusDx offers compounded semaglutide injections starting at $149 per month—a flat rate regardless of dose escalation—plus oral and dual-compound options like GLP-Squared for patients seeking different delivery methods or synergistic effects.

Getting Started With Personalized GLP-1 Therapy

PlexusDx serves all 50 states with no insurance required and no membership fees, making compounded GLP-1 medication accessible to patients regardless of coverage status. Medications come from licensed 503A compounding pharmacies and are HSA/FSA eligible. Your initial dose may be lower to assess tolerability, with adjustments guided by your response and tolerance over weeks.

After your first month of treatment, PlexusDx offers the Precision Peptide Genetic Test ($99 add-on), which analyzes 14 appetite-control pathways, 49 peptides, and 150+ genetic insights including GLP1R, GIPR, FTO, and MC4R variants. This test predicts which pathway strengths and weaknesses may influence your medication response, allowing your provider to optimize your therapy—whether sticking with semaglutide or switching to tirzepatide or a dual-compound protocol. Remember: your dose may need to go up, but your price won't.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What exactly does GLP-1 stand for and why does it matter for weight loss?

GLP-1 stands for glucagon-like peptide-1, a natural hormone your body produces that signals fullness to the brain. Medications that mimic GLP-1 amplify this signal, reducing hunger and helping you eat smaller portions without constant effort. PlexusDx uses compounded GLP-1 drugs to activate this proven biological pathway.

How quickly do GLP-1 medications like semaglutide start working?

Many patients notice reduced appetite within days to a week of starting semaglutide, though consistent weight loss typically appears over 2–4 weeks as your body adjusts to smaller food intake. The dose is gradually increased to optimize results while minimizing side effects, and PlexusDx maintains flat monthly pricing throughout dose escalation.

Are compounded GLP-1 medications from PlexusDx as safe as brand-name versions?

PlexusDx sources all compounded medications from licensed 503A compounding pharmacies, which operate under strict FDA oversight and quality standards. While compounded medications are not FDA-approved as brand-name drugs are, they contain the same active pharmaceutical ingredients prepared to pharmaceutical-grade specifications.

What is the Precision Peptide Genetic Test and does it help choose between semaglutide and tirzepatide?

The Precision Peptide Genetic Test ($99) analyzes your genes in 14 appetite-control pathways, including GLP1R, GIPR, FTO, and MC4R variants. Your results reveal which pathways are your genetic strengths and weaknesses, helping your provider decide whether you'll likely respond better to semaglutide (GLP-1 only) or tirzepatide (dual GIP/GLP-1 activation).

Will I need to stay on GLP-1 medication forever, or is it temporary?

GLP-1 therapy works while you're taking it; stopping medication typically leads to appetite and weight returning over weeks. Many patients use these medications long-term as a sustainable tool for weight management, similar to how people manage other chronic conditions. Your provider at PlexusDx can discuss whether ongoing therapy or planned breaks make sense for your goals.

Related Reading

• Orderly Meds Glp 1
• Henry Meds Glp 1
• Direct Meds Glp 1
• Remedy Meds Glp 1

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.